Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?
Year: 2024
Type: article
Study design: Case Report
Source: Anti-Cancer Drugs
Institution: Ankara Bilkent City Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404960255
